PAPAyA: a platform for breast cancer biomarker signature discovery, evaluation and assessment

BACKGROUND: The decision environment for cancer care is becoming increasingly complex due to the discovery and development of novel genomic tests that offer information regarding therapy response, prognosis and monitoring, in addition to traditional histopathology. There is, therefore, a need for tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Janevski, Angel, Kamalakaran, Sitharthan, Banerjee, Nilanjana, Varadan, Vinay, Dimitrova, Nevenka
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Proceedings
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745694/
https://www.ncbi.nlm.nih.gov/pubmed/19761577
http://dx.doi.org/10.1186/1471-2105-10-S9-S7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745694/
https://www.ncbi.nlm.nih.gov/pubmed/19761577
http://dx.doi.org/10.1186/1471-2105-10-S9-S7

Ejemplares similares